Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by mkprovoson Jun 25, 2010 2:53pm
498 Views
Post# 17222728

great deal

great dealFYI: Anyone else that likes to gamble.

Check out TSTR - could be a year long play.  Possible Bankruptcy, but majority of the debt owned by a company (Harbinger)  that wants to buy it out.  Harbinger has enough deterents in place (real threats of bankruptcy) to ensure the price stays low for an easy buyout by them but no worry about anyone else buying it out.   

I think thye are just waiting to raise the capital to buy the remainder of what they don't own.  At
.40 it is a great steal.   
Bullboard Posts